Schizophrenia and bipolar disorder are devastating diseases that affect over 60M people worldwide. These complex conditions have both genetic and environmental underpinnings and are difficult to treat. Serious mental illness often leads to socioeconomic challenges including poverty and incarceration. The average life expectancy of a person with schizophrenia can be twenty years shorter than the general population.
Altimate Health is committed to improving the health and well-bring of patients with serious mental illness (SMI). The innovative use of data science will need to new paradigm-changing therapeutic and care options. We are building integrated solutions that combine care management, decision support, and therapeutic devices to improve the health and well-being of these patients.